Cancer morbidity and mortality after pediatric solid organ transplantation-a nationwide register study
Open Access
- 1 September 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Pediatric Nephrology
- Vol. 35 (9), 1719-1728
- https://doi.org/10.1007/s00467-020-04546-y
Abstract
Background The prevalence of malignancies after pediatric solid organ transplantation was evaluated in a nationwide study. Methods All patients who had undergone kidney, liver, or heart transplantation during childhood between the years 1982 and 2015 in Finland were identified. The inclusion criteria were age under 16 years at transplantation and age over 18 years at the last follow-up day. A total of 233 (137 kidney, 53 liver, and 43 heart) transplant recipients were enrolled. Controls (n = 1157) matched by the year of birth, gender, and hometown were identified using the Population Register Center registry. The cancer diagnoses were searched using the Finnish Cancer Registry. Results Altogether 26 individuals diagnosed with cancer were found, including 18 transplant recipients. Cancer was diagnosed at a median of 12.0 (IQR 7.8-17.8) years after the transplantation. The transplant recipients' risk for cancer was significantly higher when compared with the controls (HR 14.7; 95% CI 6.4-33.9). There was no difference for different graft types. Sixty-one percent of cancers among the transplant recipients were diagnosed at age older than 18 years. Conclusion The risk for cancer is significantly higher among young adults having undergone solid organ transplantation during childhood in comparison with population controls. Careful follow-up and attention to prevent cancers throughout adulthood are warranted.Funding Information
- Lastentautien Tutkimussäätiö
- Pirkanmaan Sairaanhoitopiiri
- Orionin Tutkimussäätiö (none)
- Paulon Säätiö (none)
- Munuaissäätiö (none)
This publication has 36 references indexed in Scilit:
- Spectrum of Cancer Risk Among US Solid Organ Transplant RecipientsJAMA, 2011
- Improved Survival with Recent Post-Transplant Lymphoproliferative Disorder (PTLD) in Children with Kidney TransplantsAmerican Journal of Transplantation, 2011
- Post-transplant lymphoproliferative disease (PTLD): Pharmacological, virological and other determinantsPharmacological Research, 2011
- Pediatric Organ Transplantation and Risk of Premalignant and Malignant Tumors in SwedenAmerican Journal of Transplantation, 2011
- Comparison of the Incidence of Malignancy in Recipients of Different Types of Organ: A UK Registry AuditAmerican Journal of Transplantation, 2010
- Post‐transplant lymphoproliferative disorder in children: Recent outcomes and response to dual rituximab/low‐dose chemotherapy combinationPediatric Transplantation, 2010
- Cancer incidence and risk factors after solid organ transplantationInternational Journal of Cancer, 2009
- Immunosuppressive Therapy and Malignancy in Organ Transplant RecipientsDrugs, 2007
- Infections in pediatric solid organ transplant recipientsSeminars in Pediatric Surgery, 2006
- Risk factors for cardiovascular disease in pediatric renal transplant recipientsPediatric Transplantation, 2004